Kazazian Asset Management’s AstraZeneca AZN Stock Holding History

Kazazian Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,506	Closed	-$455K	–	89
2018 Q1	$455K	Hold	6,506	–	–	0.48%	50
2017 Q4	$452K	Buy	6,506 +674	+12%	+$45.5K	0.46%	50
2017 Q3	$395K	Buy	5,832 +696	+14%	+$44K	0.48%	46
2017 Q2	$350K	Sell	5,136 -1,004	-16%	-$65.6K	0.53%	35
2017 Q1	$382K	Hold	6,140	–	–	0.53%	27
2016 Q4	$335K	Buy	6,140 +2,300	+60%	+$131K	0.47%	28
2016 Q3	$252K	Hold	3,840	–	–	0.42%	28
2016 Q2	$232K	Hold	3,840	–	–	0.39%	28
2016 Q1	$216K	Sell	3,840 -179	-4%	-$10.8K	0.41%	29
2015 Q4	$273K	Sell	4,019 -2,490	-38%	-$163K	0.37%	33
2015 Q3	$414K	Sell	6,509 -16,823	-72%	-$1.11M	0.52%	38
2015 Q2	$1.49M	Buy	+23,332	New	+$1.6M	1.47%	13

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Kazazian Asset Management's AZN Position: Q2 2018 in Review

Kazazian Asset Management sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 6,506 shares — an estimated $455K sold.

Kazazian Asset Management first reported a position in AZN in Q2 2015 and held it in 12 quarters. The position peaked at $1.49M in Q2 2015. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

Kazazian Asset Management reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
Kazazian Asset Management sold 6,506 AstraZeneca shares in Q2 2018, an estimated $455K.
Kazazian Asset Management first reported a position in AstraZeneca in Q2 2015 and held it in 12 quarters.
Kazazian Asset Management's AstraZeneca position peaked at $1.49M in Q2 2015.
530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on Kazazian Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.